home / stock / vnrx / vnrx news


VNRX News and Press, VolitionRX Limited From 05/02/22

Stock Information

Company Name: VolitionRX Limited
Stock Symbol: VNRX
Market: NYSE
Website: volition.com

Menu

VNRX VNRX Quote VNRX Short VNRX News VNRX Articles VNRX Message Board
Get VNRX Alerts

News, Short Squeeze, Breakout and More Instantly...

VNRX - Volition (VNRX) NobleCon18 Presentation Replay

Volition (VNRX) formal corporate presentation from NobleCon18 - Noble Capital Markets 18th Annual Small & Microcap Investor Conference - April 2022. Read More >>

VNRX - Volition launches Nu.Q Vet Cancer Test in Asia via distributor

VolitionRx (NYSE:VNRX) said it launched Nu.Q Vet Cancer Test for  companion animals in Asia through its distributor SAGE Healthcare. "Adding the Nu.Q® Vet Cancer Test to the routine wellness check-up for older dogs and at-risk breeds could help detect cancer early, when treatme...

VNRX - Volition Launches its Nu.Q® Vet Cancer Test in Asia Through its Appointed Distributor SAGE Healthcare

Volition Launches its Nu.Q® Vet Cancer Test in Asia Through its Appointed Distributor SAGE Healthcare PR Newswire AUSTIN, Texas , April 25, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics compa...

VNRX - Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process

Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process PR Newswire AUSTIN, Texas , April 6, 2022 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced the a...

VNRX - VolitionRX (VNRX) Investor Presentation - Slideshow

The following slide deck was published by VolitionRx Limited in conjunction with this event. For further details see: VolitionRX (VNRX) Investor Presentation - Slideshow

VNRX - VolitionRx Limited (VNRX) CEO Cameron Reynolds on Q4 2021 Results - Earnings Call Transcript

VolitionRx Limited (VNRX) Q4 2021 Results Conference Call March 31, 2022 08:00 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Terig Hughes - Chief Financial Officer Tom Butera - Chief Executive ...

VNRX - VolitionRX reports FY results

VolitionRX press release (NYSE:VNRX): FY Cash and cash equivalents of $20.6M net loss of of $27M (+32.4% Y/Y). For further details see: VolitionRX reports FY results

VNRX - VolitionRx Limited Announces Full Fiscal Year 2021 Financial Results and Business Update

VolitionRx Limited Announces Full Fiscal Year 2021 Financial Results and Business Update PR Newswire Conference call to discuss financial and operational results scheduled for Thursday, March 31 , at 8:00am U.S. Eastern Time · Executed glob...

VNRX - SAN, STLA and EPAM among pre market gainers

Guardforce AI (GFAI) +46% is expanding it footprint by establishing subsidiaries in Dubai and Australia. IGM Biosciences (IGMS) +32% on proposed stock offering. Hycroft Mining Holding (HYMC) +23% GameStop, AMC and Bed Bath pull off a meme stock comeback. Nielsen Holdi...

VNRX - Heska Corporation Signs Exclusive Agreement to Introduce Nu.Q® Vet Cancer Screening Test, First-Ever Point of Care Cancer Screen

Heska Corporation Signs Exclusive Agreement to Introduce Nu.Q® Vet Cancer Screening Test, First-Ever Point of Care Cancer Screen PR Newswire LOVELAND, Colo. , March 29, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA) ("Heska"), a leading global...

Previous 10 Next 10